Clinical Biochemistry — MCQs

Clinical Biochemistry Indian Medical PG Practice Questions and MCQs

Question 101: Serum alkaline phosphatase is elevated in which of the following conditions?

A. Primary biliary cirrhosis (Correct Answer)
B. Hypophosphatemia
C. Hyperphosphatemia
D. Hepatitis A

Explanation: **Explanation:** **Alkaline Phosphatase (ALP)** is a group of isoenzymes that catalyze the hydrolysis of organic phosphate esters at an alkaline pH. In clinical practice, it is primarily used as a marker for **cholestatic liver disease** and **bone disorders** involving osteoblastic activity. **1. Why Primary Biliary Cirrhosis (PBC) is correct:** PBC is a chronic autoimmune disease characterized by the destruction of small intrahepatic bile ducts. This leads to **cholestasis** (obstruction of bile flow). In cholestasis, the increased pressure and the detergent action of bile salts on the bile canalicular membranes induce the synthesis and release of ALP into the bloodstream. ALP is a highly sensitive marker for obstructive jaundice; levels often rise 3 to 10 times the upper limit of normal. **2. Why the other options are incorrect:** * **Hypophosphatemia/Hyperphosphatemia:** Serum ALP levels are generally independent of serum inorganic phosphate levels. While ALP is involved in phosphate metabolism, its serum concentration is not a diagnostic marker for simple electrolyte imbalances. * **Hepatitis A:** While ALP may be mildly elevated in viral hepatitis, the primary markers are the transaminases (ALT and AST). A disproportionately high ALP compared to ALT/AST points toward a cholestatic pattern (like PBC) rather than a hepatocellular pattern (like Hepatitis A). **Clinical Pearls for NEET-PG:** * **Source of ALP:** Liver (Canalicular membrane), Bone (Osteoblasts), Placenta, and Intestine. * **Heat Stability Rule:** "Regan Isoenzyme" (Placental) is the most heat-stable, while the Bone isoenzyme is the most heat-labile (**B**one = **B**urns). * **GGT Correlation:** To differentiate if elevated ALP is from the liver or bone, check **Gamma-glutamyl transferase (GGT)**. GGT is elevated in liver disease but remains normal in bone disease. * **Other high-yield causes of high ALP:** Paget’s disease of bone, Rickets/Osteomalacia, and Space-occupying lesions in the liver (e.g., metastasis).

Question 102: Which of the following immunoglobulins has the highest mean serum concentration in humans?

A. IgA
B. IgD
C. IgG (Correct Answer)
D. IgM

Explanation: **Explanation:** The correct answer is **IgG**. In healthy adults, IgG is the most abundant class of immunoglobulin, accounting for approximately **75–80%** of the total serum antibodies. Its high concentration (800–1600 mg/dL) is due to its long half-life (about 21 days) and its role as the primary mediator of the secondary immune response. **Why the other options are incorrect:** * **IgA (Option A):** It is the second most common serum immunoglobulin (~15%). While it is the most abundant antibody in **secretions** (tears, saliva, colostrum), its serum levels are significantly lower than IgG. * **IgM (Option B):** It accounts for about 5–10% of serum antibodies. It is the largest in size (pentamer) and the first to appear in a primary immune response, but it has a shorter half-life and lower concentration than IgG. * **IgD (Option D):** It is found in trace amounts in the serum (<1%). Its primary role is as a B-cell surface receptor. **High-Yield NEET-PG Pearls:** * **GAMED:** Use this mnemonic to remember the order of serum concentration: **IgG > IgA > IgM > IgD > IgE**. * **Placental Transfer:** IgG is the **only** immunoglobulin that crosses the placenta, providing passive immunity to the fetus. * **Complement Activation:** IgM is the most potent activator of the classical complement pathway (due to its pentameric structure), followed by IgG. * **Multiple Myeloma:** IgG is the most common monoclonal protein (M-spike) found in Multiple Myeloma, followed by IgA.

Question 103: A patient's lipid profile shows Triglycerides (TG) of 200 mg/dL, Total Cholesterol of 300 mg/dL, and HDL of 40 mg/dL. Calculate the LDL level in this patient.

A. 40 mg/dL
B. 100 mg/dL
C. 220 mg/dL (Correct Answer)
D. 260 mg/dL

Explanation: To calculate the LDL (Low-Density Lipoprotein) cholesterol level, we use the **Friedewald Formula**, which is a high-yield concept for NEET-PG Biochemistry. ### **The Formula:** **LDL = Total Cholesterol – HDL – (Triglycerides / 5)** *(Note: TG/5 represents VLDL cholesterol, provided TG levels are <400 mg/dL).* ### **Step-by-Step Calculation:** 1. **Identify the values:** Total Cholesterol = 300, HDL = 40, TG = 200. 2. **Calculate VLDL:** TG / 5 = 200 / 5 = **40 mg/dL**. 3. **Calculate LDL:** 300 – 40 (HDL) – 40 (VLDL) = **220 mg/dL**. ### **Analysis of Options:** * **C (220 mg/dL):** Correct. This is the result of the standard Friedewald calculation. * **A (40 mg/dL):** Incorrect. This represents only the HDL or the calculated VLDL component. * **B (100 mg/dL):** Incorrect. This might result from a calculation error or confusing the target LDL level with the calculated one. * **D (260 mg/dL):** Incorrect. This value is obtained if one forgets to subtract the VLDL (TG/5) component (300 - 40 = 260). ### **Clinical Pearls for NEET-PG:** * **Limitation:** The Friedewald formula is **invalid** if Triglycerides are **>400 mg/dL** or if the patient has Type III Hyperlipoproteinemia (Dysbetalipoproteinemia). * **Sample Requirement:** For an accurate lipid profile, a **12-14 hour fasting** sample is preferred to minimize the impact of chylomicrons on TG levels. * **Direct LDL:** If TG >400 mg/dL, LDL must be measured directly using ultracentrifugation or homogenous assays rather than the formula.

Question 104: Rothera's test is used for detecting which substance in urine?

A. Bilirubin
B. Glucose
C. Protein
D. Ketone bodies (Correct Answer)

Explanation: **Explanation:** **Rothera’s test** is the standard biochemical method used to detect **Ketone bodies** in urine. The test utilizes **Sodium Nitroprusside** in the presence of alkali (ammonia). It specifically reacts with **acetoacetate** and **acetone** to produce a characteristic **permanganate-colored (purple/violet) ring** at the junction of the fluids. Note that it does not detect beta-hydroxybutyrate, which is the predominant ketone body in diabetic ketoacidosis. **Analysis of Incorrect Options:** * **A. Bilirubin:** Detected using **Fouchet’s test**, where barium chloride is used to precipitate bilirubin, followed by the addition of Fouchet’s reagent to produce a green/blue color. * **B. Glucose:** Detected using **Benedict’s test**, which relies on the reducing property of glucose to convert cupric ions to cuprous oxide, resulting in a color change from blue to brick red. * **C. Protein:** Commonly detected using the **Heat and Acetic Acid test** (coagulation) or the **Sulphosalicylic acid test** (turbidity). **High-Yield Clinical Pearls for NEET-PG:** * **Gerhardt’s Test:** Specifically detects acetoacetate (using ferric chloride) but is less sensitive than Rothera’s. * **Ketone Body Composition:** In DKA, the ratio of $\beta$-hydroxybutyrate to acetoacetate increases significantly. Since Rothera’s test only detects the latter, it may initially underestimate the severity of ketosis. * **False Positives:** Drugs containing sulfhydryl groups (e.g., Captopril, Penicillamine) can give a false-positive Rothera’s test. * **Hay’s Test:** Used for detecting **Bile Salts** (based on surface tension).

Question 105: A patient presents with complains of sciatica. On radiological examination, there are sclerotic lesions on his skull. Which of the following is most likely to be elevated in this patient?

A. CEA
B. Prostate specific antigen (Correct Answer)
C. Alkaline phosphatase
D. Alpha 1 antitrypsin

Explanation: **Explanation:** The clinical presentation of **sciatica** (often caused by nerve root compression) combined with **sclerotic (osteoblastic) lesions** on the skull or spine in an elderly male is a classic hallmark of **Metastatic Prostate Cancer**. 1. **Why PSA is correct:** Prostate cancer is the most common malignancy to produce **osteoblastic (bone-forming) metastases**. These lesions appear radiodense or "sclerotic" on X-ray. **Prostate-Specific Antigen (PSA)** is the specific tumor marker used for screening, monitoring, and diagnosing prostate adenocarcinoma. In the context of bony metastasis, PSA levels are typically significantly elevated. 2. **Why other options are incorrect:** * **CEA (Carcinoembryonic Antigen):** Primarily a marker for colorectal carcinoma. While it can be elevated in various cancers, it is not associated with sclerotic bone lesions. * **Alkaline Phosphatase (ALP):** While ALP *would* be elevated in this patient (due to increased osteoblastic activity), the question asks for the "most likely" specific marker. PSA is the definitive marker for the underlying primary malignancy (Prostate CA) causing these specific lesions. (Note: In some exams, if PSA isn't an option, ALP is the next best choice for bone turnover). * **Alpha-1 Antitrypsin:** A protease inhibitor; deficiency leads to emphysema and liver cirrhosis, not sclerotic bone lesions. **Clinical Pearls for NEET-PG:** * **Osteoblastic (Sclerotic) Metastases:** Think Prostate Cancer (Most common), Breast Cancer (can be mixed), or Carcinoid. * **Osteolytic (Lucent) Metastases:** Think Multiple Myeloma, Renal Cell Carcinoma, Lung Cancer, and Thyroid Cancer. * **Acid Phosphatase (Tartrate-resistant):** Historically used for prostate cancer, but now replaced by the more sensitive PSA.

Question 106: Increased serum acid phosphatase is a laboratory finding of which condition?

A. Osteopetrosis (Correct Answer)
B. Hyperparathyroidism
C. Fibrous dysplasia
D. Scurvy

Explanation: **Explanation:** **1. Why Osteopetrosis is Correct:** Acid phosphatase, specifically the **Tartrate-Resistant Acid Phosphatase (TRAP)** isoform, is a biochemical marker of **osteoclast activity**. Osteopetrosis (Marble Bone Disease) is characterized by a functional defect in osteoclasts (often due to a deficiency in carbonic anhydrase II), leading to impaired bone resorption. Despite the failure to resorb bone, there is a reactive **increase in the number of osteoclasts** and their enzymatic secretion, resulting in significantly elevated serum acid phosphatase levels. **2. Why the Other Options are Incorrect:** * **Hyperparathyroidism:** This condition involves increased bone remodeling. While osteoclast activity is high, the hallmark laboratory finding is elevated **Alkaline Phosphatase (ALP)** (due to coupled osteoblastic activity) and hypercalcemia. Acid phosphatase is not the primary diagnostic marker here. * **Fibrous Dysplasia:** This is a localized bone disorder where normal bone is replaced by fibrous tissue. While ALP may be mildly elevated during active growth phases, serum acid phosphatase remains normal. * **Scurvy:** Caused by Vitamin C deficiency, it leads to defective collagen synthesis and decreased osteoblastic activity. Laboratory findings typically show normal levels of calcium, phosphate, and acid phosphatase. **3. Clinical Pearls for NEET-PG:** * **TRAP Marker:** TRAP is not only a marker for osteoclasts but is also the classic diagnostic marker for **Hairy Cell Leukemia**. * **Prostate Connection:** Historically, **Prostatic Acid Phosphatase (PAP)** was used to monitor prostate cancer, but it has been largely replaced by PSA (Prostate-Specific Antigen). * **Osteopetrosis Triad:** Look for "Erlenmeyer flask" deformity on X-ray, pancytopenia (due to marrow obliteration), and cranial nerve palsies. * **ALP vs. ACP:** Remember, **Alkaline** Phosphatase = **Osteoblast** activity; **Acid** Phosphatase = **Osteoclast** activity.

Question 107: Serum creatine kinase-3 (CK-3) is elevated in which of the following conditions?

A. Muscular dystrophy (Correct Answer)
B. Myocardial infarction
C. Alcoholic cirrhosis
D. Brain tumours

Explanation: ### Explanation Creatine Kinase (CK) is a dimeric enzyme composed of two subunits: **M (Muscle)** and **B (Brain)**. These subunits combine to form three distinct isoenzymes. **CK-3 (CK-MM)** is the predominant form found in skeletal muscle (98%) and cardiac muscle. **1. Why Muscular Dystrophy is Correct:** Elevated levels of CK-3 are a hallmark of skeletal muscle damage. In **Duchenne Muscular Dystrophy (DMD)**, the lack of dystrophin leads to increased membrane permeability, causing massive leakage of CK-MM into the serum. It is often elevated even before clinical symptoms appear. **2. Analysis of Incorrect Options:** * **Myocardial Infarction (MI):** While CK-3 is present in the heart, **CK-2 (CK-MB)** is the specific diagnostic marker for MI. CK-MB levels rise within 4–8 hours of an infarct. * **Alcoholic Cirrhosis:** Liver diseases typically involve elevations in ALT, AST, and GGT. CK is not found in significant quantities in hepatocytes; therefore, cirrhosis does not elevate serum CK-3. * **Brain Tumors:** The brain contains the **CK-1 (CK-BB)** isoenzyme. Damage to the blood-brain barrier or neural tissue (like tumors or infarction) may lead to an increase in CK-BB, not CK-3. **3. High-Yield Clinical Pearls for NEET-PG:** * **Isoenzyme Distribution:** * **CK-1 (BB):** Brain, Prostate, Gastrointestinal tract. * **CK-2 (MB):** Cardiac muscle (20–30%), Skeletal muscle (1–2%). * **CK-3 (MM):** Skeletal muscle (98%), Cardiac muscle (70–80%). * **Highest Elevations:** The highest serum CK levels (often >50 times normal) are seen in **Duchenne Muscular Dystrophy** and **Rhabdomyolysis**. * **Electrophoretic Mobility:** On electrophoresis (pH 8.6), CK-1 (BB) moves fastest toward the anode, while CK-3 (MM) moves slowest.

Question 108: A patient presents with low serum calcium, high phosphorus and elevated PTH. Which of the following investigations is least contributory to establish a diagnosis?

A. Vitamin D levels (Correct Answer)
B. Serum creatinine levels
C. Cyclic AMP response to PTH
D. Urine myoglobin

Explanation: ### **Explanation** The clinical presentation of **low serum calcium, high phosphorus, and elevated PTH** indicates a state of **PTH resistance** or **secondary hyperparathyroidism** due to renal failure. 1. **Why Vitamin D levels (Option A) is the correct answer:** In Vitamin D deficiency (Osteomalacia/Rickets), the typical biochemical profile is low calcium and **low phosphorus** (due to secondary hyperparathyroidism causing phosphaturia). Since this patient has **high phosphorus**, Vitamin D deficiency is unlikely. Therefore, measuring Vitamin D levels is the least contributory investigation for differentiating between the likely diagnoses of Pseudohypoparathyroidism or Chronic Kidney Disease (CKD). 2. **Analysis of Incorrect Options:** * **Serum Creatinine (Option B):** Essential to rule out **Chronic Kidney Disease (CKD)**. In CKD, decreased GFR leads to phosphate retention (high phosphorus) and low calcitriol, resulting in low calcium and high PTH. * **Cyclic AMP response to PTH (Option C):** This is the **Ellsworth-Howard test**, used to diagnose **Pseudohypoparathyroidism (PHP)**. In PHP, there is end-organ resistance to PTH; a failure of urinary cAMP to rise after exogenous PTH administration confirms the diagnosis. * **Urine Myoglobin (Option D):** Relevant in the context of **Rhabdomyolysis**, which causes acute renal failure, hyperphosphatemia (released from muscle), and hypocalcemia (precipitation with phosphate). ### **High-Yield Clinical Pearls for NEET-PG** * **Pseudohypoparathyroidism (PHP):** Characterized by PTH resistance. Look for **Albright’s Hereditary Osteodystrophy** (short stature, round face, short 4th/5th metacarpals). * **Biochemical Triad of PHP:** ↓ Ca²⁺, ↑ PO₄³⁻, ↑ PTH (identical to CKD, but with normal renal function). * **Vitamin D Deficiency:** ↓ Ca²⁺, **↓ PO₄³⁻**, ↑ PTH. * **Hypoparathyroidism:** ↓ Ca²⁺, ↑ PO₄³⁻, **↓ PTH**.

Question 109: After suffering a seizure, a 23-year-old woman is found to have profound hypoglycemia. Determination of which of the following would aid in differentiating exogenous hyperinsulinemia from endogenous hyperinsulinemia?

A. C-peptide (Correct Answer)
B. Gastrin
C. Glucagon
D. Proinsulin

Explanation: ### Explanation **Concept:** Insulin is synthesized in the pancreatic beta cells as **proinsulin**. Before secretion, proinsulin is cleaved into equimolar amounts of **mature insulin** and **C-peptide** (Connecting peptide). 1. **Endogenous Hyperinsulinemia** (e.g., Insulinoma or Sulfonylurea use): The body produces insulin naturally, meaning C-peptide is released into the bloodstream alongside insulin. Therefore, C-peptide levels will be **elevated**. 2. **Exogenous Hyperinsulinemia** (Factitious/Injection): Commercial insulin preparations contain only the active insulin hormone and lack C-peptide. Therefore, in cases of exogenous overdose, insulin levels are high, but C-peptide levels are **suppressed** due to negative feedback on the pancreas. **Analysis of Options:** * **A. C-peptide (Correct):** It is the most reliable marker to distinguish the two. High Insulin + High C-peptide = Endogenous source. High Insulin + Low C-peptide = Exogenous source. * **B. Gastrin:** This is a marker for Gastrinoma (Zollinger-Ellison Syndrome). While it can be part of MEN1 (alongside insulinomas), it does not differentiate the source of insulin. * **C. Glucagon:** This counter-regulatory hormone increases blood glucose but does not help identify the origin of circulating insulin. * **D. Proinsulin:** While elevated in insulinomas (due to inefficient processing), it is not as definitive as C-peptide for ruling out exogenous intake, as some proinsulin may still be suppressed by exogenous insulin. **NEET-PG High-Yield Pearls:** * **Equimolar Secretion:** Insulin and C-peptide are secreted in a 1:1 ratio. * **Half-life:** C-peptide has a longer half-life (approx. 30 mins) than insulin (approx. 5 mins), making it a stable marker of beta-cell function. * **Factitious Hypoglycemia:** Suspect this in healthcare workers with access to insulin. They will present with hypoglycemia, high insulin, and low C-peptide. * **Sulfonylureas:** These drugs stimulate endogenous insulin release; thus, they cause high insulin AND high C-peptide (differentiated from insulinoma by a urine drug screen).

Question 110: What is the normal creatinine level in adults?

A. 0.8 - 1.2 mg/dL (Correct Answer)
B. 1.0 - 2.0 mg/dL
C. 2.2 - 3.0 mg/dL
D. 3.0 - 3.8 mg/dL

Explanation: **Explanation:** Creatinine is a metabolic byproduct of **creatine phosphate** in muscle tissue. It is produced at a constant rate proportional to muscle mass and is excreted primarily by the kidneys through glomerular filtration. **1. Why Option A is correct:** In healthy adults, the normal serum creatinine range is typically **0.8 to 1.2 mg/dL** (though it can vary slightly by gender: 0.7–1.3 mg/dL for men and 0.6–1.1 mg/dL for women). Because it is minimally reabsorbed or secreted by the tubules, it serves as a reliable endogenous marker for estimating the **Glomerular Filtration Rate (GFR)**. **2. Why the other options are incorrect:** * **Option B (1.0 - 2.0 mg/dL):** While the lower end is normal, values above 1.3–1.4 mg/dL usually indicate early stages of renal impairment or decreased GFR. * **Options C & D (2.2 - 3.8 mg/dL):** These levels represent significant **azotemia**. Such elevations are seen in acute kidney injury (AKI) or chronic kidney disease (CKD) and are often associated with clinical symptoms of uremia. **Clinical Pearls for NEET-PG:** * **Jaffe’s Reaction:** The most common laboratory method to estimate creatinine, using **alkaline picrate** to form a red-orange complex. * **Muscle Mass Factor:** Creatinine levels are lower in children, the elderly, and individuals with muscle-wasting diseases. * **Creatinine Clearance ($C_{cr}$):** Used to estimate GFR. Formula: $U \times V / P$ (where $U$ = urine creatinine, $V$ = urine volume, $P$ = plasma creatinine). * **BUN/Creatinine Ratio:** A ratio **>20:1** typically suggests pre-renal azotemia (e.g., dehydration).

Practice by Chapter

Liver Function Tests

Practice Questions

Kidney Function Tests

Practice Questions

Cardiac Markers and Enzymes

Practice Questions

Pancreatic Function Tests

Practice Questions

Glucose Tolerance Tests

Practice Questions

Lipid Profile and Cardiovascular Risk

Practice Questions

Tumor Markers

Practice Questions

Hormonal Assays and Interpretation

Practice Questions

Electrolytes and Acid-Base Balance Tests

Practice Questions

Cerebrospinal Fluid Analysis

Practice Questions

Point-of-Care Testing

Practice Questions

Quality Control in Clinical Biochemistry

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free